Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of OXTR mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of OXTR mRNA | increases expression | 18687144
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of OXTR mRNA | affects expression | 20382639
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of OXTR mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
OXTR protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 11313874
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased activity of OXTR protein | increases activity | 12834913
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of OXTR mRNA | increases expression | 15834898
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of OXTR mRNA | increases expression | 18035473
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of OXTR mRNA | decreases expression | 12057914
|
D008731 |
Methoxychlor |
Methoxychlor results in decreased expression of OXTR protein | decreases expression | 16307867
|
D015735 |
Mifepristone |
Mifepristone inhibits the reaction [OXT protein binds to OXTR protein] | affects binding|decreases reaction | 16797624
|
D016226 |
Phosphorus, Dietary |
Phosphorus, Dietary affects the expression of OXTR mRNA | affects expression | 16311027
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OXTR mRNA | affects binding|decreases expression|increases activity | 19710929
|
C025299 |
polyphenols |
polyphenols results in decreased expression of OXTR mRNA | decreases expression | 16293270
|
D011374 |
Progesterone |
Progesterone results in decreased expression of OXTR mRNA | decreases expression | 18070364
|
D011374 |
Progesterone |
Progesterone inhibits the reaction [OXT protein binds to OXTR protein] | affects binding|decreases reaction | 17629525 16254031
|
D011374 |
Progesterone |
Progesterone affects the expression of OXTR | affects expression | 17765941
|
D013629 |
Tamoxifen |
Tamoxifen results in increased activity of OXTR protein | increases activity | 12834913
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of OXTR mRNA | decreases expression | 20044593
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of OXTR mRNA | increases expression | 20044593
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.87 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.06 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.06 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.39 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.39 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.55 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17893705 18207134 17383819 15992526 21082655 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.73 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.27 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.81 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.34 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.34 | 15136595 11325840 19526202 18382427 16096432 15692762 18234424 15994142 18628466 16595493 15939500 17426702 18695136 16264153 15567936 16826403 16935488 17369602 15993339 15634643 16322301 15668708 16115903 17983394 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.34 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.34 | 19155303 17242785 19189210 19487384 17893378 20065188 19189212 19289846 18351453 19288272 11161223 18997820 19103187 18821012 19142967 20859285 19011961 18425577 19244106 20005174 19084267 19410462 18815881 15565566 18629630 20544844 18855134 16818667 20135344 17049068 16273361 20390343 19221464 17440819 16202921 18984771 19059307 19115204 21138602 19066611 19200415 17261762 21152245 16873071 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.84 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.52 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.16 | 16234567 17876044 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.16 | 16924424 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
marker/mechanism |
|
| 17043644 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.16 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.91 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.91 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.62 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.53 | 16109756 17519947 16278810 16364871 16952015 16612575 15505089 16651473 15811867 17351982 17974986 15476868 17924179 16731534 15792986 17329180 16269455 17308081 17007740 18627295 16455267 17131338 17382496 17928571 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.94 | 17334414 16243910 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.73 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 20832055 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.75 | 15861022 17333356 17110522 16919318 17681005 16105132 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.75 | 19176532 |
MESH:C536807 |
Chromosome 3, monosomy 3p25 |
marker/mechanism |
|
| 21082655 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 15340226 16354765 8697196 12621046 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.67 | 16293270 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 20055451 15322242 10048152 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.38 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.48 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.34 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.34 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.34 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.12 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.12 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.55 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
22.03 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
22.03 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
22.03 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
22.03 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.57 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.57 | 16202921 20544844 19155303 17893378 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
15.36 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
15.36 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
15.36 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.19 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.42 | 15821434 15328337 17637181 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.07 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.07 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
13.07 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.24 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.02 | 11852909 9205823 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
11.51 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.51 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.96 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.35 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.53 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.48 | 17888722 18674790 16330681 16495754 16707910 16144979 17875725 12587719 14766674 16244371 16244372 18006777 16879835 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.05 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.05 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.90 | 15692506 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.39 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.41 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 16959395 8697196 18606429 15340226 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.91 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.11 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methoxychlor |
7.11 | 16467254 11955947 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
20.02 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
20.02 | 9205823 12878042 17255318 17963957 17237260 |
MESH:D007249 |
Inflammation |
|
polyphenols |
20.02 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
20.02 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
20.02 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
20.02 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.64 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.05 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.16 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.04 | 18625569 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.19 | 16085563 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.72 | 15821434 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.16 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.74 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.74 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.74 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.74 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.74 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.78 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.34 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.34 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.34 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.91 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.91 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
9.35 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
9.35 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.42 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.42 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.42 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.46 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.79 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.58 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.05 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
10.05 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
10.05 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.58 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.41 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.41 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.20 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.44 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.44 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.50 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.81 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.71 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.71 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.88 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.88 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.95 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.03 | 19189210 19196722 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.78 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.00 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.26 | 15555623 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.11 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
5.21 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.21 | 16525653 17393432 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.19 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.91 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.19 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.57 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11222880 11399792 11118676 11896295 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.80 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.65 | 16644109 16289102 12479363 15754350 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.65 | 15749863 15897917 16888761 16729912 16868541 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.65 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 16919318 15861022 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.03 | 17322281 17365031 17975199 15814490 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.23 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.73 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.99 | 16767912 17710206 15625365 18313854 17203757 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.25 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.81 | 17846226 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 20196918 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.69 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.69 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.58 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.66 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.66 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.94 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.94 | 19457130 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.28 | 17997062 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.17 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.37 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.21 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.21 | 16712894 17572228 8653321 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.23 | 17638931 16364871 17334414 17678736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |